What is the cost of maintaining a kidney in upper-tract transitional-cell carcinoma? an objective analysis of cost and survival

Journal of Endourology

Volumn 23, Issue 3, 2009, Pages 341-346

  Pak, Raymond W ^a   Moskowitz, Eric J ^a   Bagley, Demetrius H ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANESTHESIA; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COHORT ANALYSIS; CONSERVATIVE TREATMENT; COST BENEFIT ANALYSIS; COST CONTROL; COST OF ILLNESS; DIALYSIS; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; KIDNEY PRESERVATION; MAJOR CLINICAL STUDY; NEPHROURETERECTOMY; PRIORITY JOURNAL; QUALITY OF LIFE; RETROSPECTIVE STUDY; SOLITARY KIDNEY; SURGEON; TRANSITIONAL CELL CARCINOMA; URETEROSCOPY; URINARY TRACT CARCINOMA; ALGORITHM; CHRONIC KIDNEY FAILURE; COST; ECONOMICS; KIDNEY; KIDNEY TUMOR; LOW LEVEL LASER THERAPY; PATHOLOGY; SURVIVAL; TIME;

AGED; ALGORITHMS; CARCINOMA, TRANSITIONAL CELL; COSTS AND COST ANALYSIS; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; LASER THERAPY; SURVIVAL ANALYSIS; TIME FACTORS; URETEROSCOPY;

EID: 65549111226     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2008.0251     Document Type: Article

References (21)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics, 2005. CA Cancer J Clin 2005;55:10-30.
2. Blute ML, Segura JW, Patterson DE, Benson RC Jr, Zincke H. Impact of endourology on diagnosis and management of upper urinary tract urothelial cancer. J Urol 1989;141:1298-1301.
3. Razdan S, Johannes J, Cox M, Bagley DH. Current practice patterns in urologic management of upper-tract transitional-cell carcinoma. J Endourol 2005;19:366-371.
4. Zincke H, Neves RJ. Feasibility of conservative surgery for transitional cell cancer of the upper urinary tract. Urol Clin North Am 1984;11:717-724.
5. Snow DC, Bhayani Sb. Rapid communication: Chronic renal insufficiency after laparoscopic partial nephrectomy and radical nephrectomy for pathologic t1a lesions. J Endourol 2008;22:337-341.
6. Meraney AM, Gill IS. Financial analysis of open versus laparoscopic radical nephrectomy and nephroureterectomy. J Urol 2002;167:1757-1762.
7. May DJ, Chandhoke PS. Efficacy and cost-effectiveness of extracorporeal shock wave lithotripsy for solitary lower pole renal calculi. J Urol 1998;159:24-27.
8. Gettman MT, Lotan Y, Roerhborn CG, Cadeddu JA, Pearle MS. Cost-effective treatment for ureteropelvic junction obstruction: A decision tree analysis. J Urol 2003;169:228-232.
9. U.S. Renal Data System, USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007.
10. Sayin A, Mutluay R, Sindel S. Quality of life in hemodialysis, peritoneal dialysis, and transplantation patients. Transplant Proc 2007;39:3047-3053.
11. Saidi R, Elias N, Kawai T, et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: Realities and costs. Am J Transplant 2007;7:2769-2774.
12. Sowter SJ, Ilie CP, Eftimiou I, Tolley DA. Endourologic management of patients with upper-tract transitional-cell carcinoma: Long-term follow-up in a single center. J Endourol 2007;21:1005-1009.
13. Thompson RH, Krambeck AE, Lohse CM, Elliott DS, Patterson DE, Blute ML Endoscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. Urology 2008;71:713-717.
14. Krambeck AE, Thompson RH, Lohse CM, Patterson DE, Elliott DS, Blute ML. Imperative indications for conservative management of upper tract transitional cell carcinoma. J Urol 2007;178:792-797.
15. Deligne E, Colombel M, Badet L, et al. Conservative management of upper urinary tract tumors. Eur Urol 2002;42:43-48.
16. Iborra I, Solsona E, Casanova J, Ricos JV, Rubio J, Climent MA. Conservative elective treatment of upper urinary tract tumors: A multivariate analysis of prognostic factors for recurrence and progression. J Urol 2003;169:82-85.
17. Milner JE, Voelzke BB, Flanigan RC, Sharma SK, Perry KT, Turk TM. Urothelial-cell carcinoma and solitary kidney: Outcomes with renal-sparing management. J Endourol 2006;20:800-807.
18. Huang WC, Levey AS, Serio AM, Snyder M, Vickers AJ, Raj GV, Scardino PT, Russo P. Chronic kidney disease after nephrectomy in patients with renal cortical tumors: A retrospective cohort study. Lancet Oncol 2006;7:735-740.
19. Chen CY, Liao YM, Tsai WM, Kuo HC. Upper urinary tract urothelial carcinoma in eastern Taiwan: High proportion among all urothelial carcinomas and correlation with chronic kidney disease. J Formos Med Assoc 2007;106:992-998.
20. Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: An SF-36 survey. Urology 2005;65:290-294.
21. Churchill DN, Torrance GW, Taylor DW, Barnes CC, Ludwin D, Shimizu A, Smith EK. Measurement of quality of life in end-stage renal disease: The time trade-off approach. Clin Invest Med 1987;10:14-20.